Schattenberg, JM; He, Y; Galle, PR et al.
ABLATION OF c-FLIP AUGMENTS CD95-AND GALACTOSAMINE/LPS-INDUCED LIVER INJURY THROUGH ACTIVATION OF c-JUN N-TERMINAL KINASE (JNK)Advances in Experimental Medicine and Biology. Bd. 691. 2011 S. 791-792
Schattenberg, JM; Zimmermann, T; Worns, M et al.
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivoJOURNAL OF HEPATOLOGY. Bd. 55. H. 6. 2011 S. 1272-1280
Gockel, HR; Gockel, I; Drescher, DG et al.
Achalasia in a patient with HIV/HCV coinfection. Detection of HCV in the esophageal tissueCHIRURG. Bd. 82. H. 11. 2011 S. 1021-1026
Moehler, M; Sieben, M; Roth, S et al.
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1BMC CANCER. Bd. 11. 2011 S. -
Rey, JW; Schreiner, O; Barreiros, AP et al.
Acute Renal and Liver Dysfunction after Subcutaneous Injection of 3-sn-Phosphatidylcholine (Lipostabil (R)) - Case ReportZEITSCHRIFT FUR GASTROENTEROLOGIE. Bd. 49. H. 3. 2011 S. 340-343
Kittner, JM; Sprinzl, MF; Grambihler, A et al.
ADD-ON OF PEG-INTERFERON TO A STABLE NUCLEOS(T)IDE REGIMEN LEADS TO LOSS OF HBS-AG IN PATIENTS WITH CHRONIC HEPATITIS BJOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S291-S291
Heinrich, S; Pestalozzi, B; Lesurtel, M et al.
Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)BMC CANCER. Bd. 11. 2011 S. -
Ben M'Barek, M; Volz, T; Lutgehetmann, M et al.
ADMINISTRATION OF THE ENTRY INHIBITOR MYRCLUDEX-B AFTER ESTABLISHMENT OF HEPATITIS B VIRUS INFECTION PREVENTS VIRAL SPREADING AMONG HUMAN HEPATOCYTES IN UPA MICEJOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S33-S33
Gamstatter, T; Weinmann, A; Schadmand-Fischer, S et al.
AFP Measurement in Monitoring Treatment Response of Advanced Hepatocellular Carcinoma to Sorafenib: Case Report and Review of the LiteratureONKOLOGIE. Bd. 34. H. 10. 2011 S. 538-542
Schmaderer, C; Xing, CJ; Anderson, G et al.
AGE formation blockade with aminoguanidine does not ameliorate chronic allograft nephropathyLIFE SCIENCES. Bd. 89. H. 11-12. 2011 S. 349-354